Healthcare "Rationing" Not Acceptable Reason For Denying Switches - FDAer
This article was originally published in The Tan Sheet
Executive Summary
The practice of "rationing" a drug, or wanting to keep it out of the hands of the general public, is not an acceptable singular reason for disapproving a switch candidate, FDA Office of Drug Evaluation V Director Robert DeLap, MD/PhD, stated at a switch summit held by the Consumer Healthcare Products Association July 16 in Washington, D.C.
You may also be interested in...
Rx-To-OTC Switch Candidate Negative Lists "Stifle Innovation" - CHPA
FDA should consider all Rx-to-OTC switch candidates on a case-by-case basis and avoid creating "presumptive negative lists" of drug classes not suited to OTC use, the Consumer Healthcare Products Association stresses in Aug. 25 comments to the agency.
OTC Statin Target Population Receives Significant FDA Attention
The type of people most suited for OTC statin therapy received considerable attention from FDA during the agency's discussion on the OTC availability of vascular drugs at a public meeting in Gaithersburg, Md. June 28-29.
OTC Switch Criteria For Chronic Illnesses, Risk Factors Differ - DeLap
Prescription drugs that treat risk factors, rather than a chronic illness, may not be ideally suited for Rx-to-OTC switches due to the danger of side effects, FDA's Robert DeLap, MD/PhD, suggested at the Drug Information Association annual meeting in San Diego June 12-13.